Floatz logo

Ivocizumab

Basal Cell Carcinomas

Fudan UniversityPhase 2
Rating in progress

Ivocizumab in Basal Cell Carcinomas is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.

Methodology v0.2 · Active